Skip to main content

Featured

Canada's Tax Cut 2026: What It Means for Your Wallet

  If you haven't noticed a slightly fatter paycheque in 2026 — you're not imagining it. Canada's middle-class tax cut is now fully in effect, and nearly 22 million Canadians are paying less federal income tax this year. The question is: how much are you actually saving, and what's the smartest thing to do with it? Here's your plain-English breakdown — no tax jargon, no fluff. What Changed — And When In July 2025, the federal government cut the lowest federal income tax rate from 15% to 14% . That rate applies to the first $58,523 of every Canadian's taxable income in 2026 — regardless of how much you earn overall. Because it kicked in mid-year, the effective 2025 rate was a blended 14.5%. In 2026, you get the full 1% reduction from January 1 . Bill C-4 (the Making Life More Affordable for Canadians Act ) received Royal Assent on March 12, 2026 — making this cut permanent law. 2026 Federal Tax Brackets at a Glance The CRA also applied a 2% indexation adjustment...
Post a Comment
Read more

article

Labels

Revolutionary Gene Therapy Restores Hearing in Deaf Toddler

 

In a remarkable medical breakthrough, an 18-month-old toddler named Opal Sandy has regained her hearing thanks to a pioneering gene therapy trial. Born deaf due to a rare genetic condition affecting the OTOF gene, which is responsible for producing a protein essential for hearing, Opal’s prospects for natural hearing were bleak. However, the innovative treatment at Cambridge University Hospitals in England has opened up a world of sound for her.

The procedure involved the infusion of a working copy of the OTOF gene into Opal’s right ear, a process that took a mere 16 minutes. Remarkably, within weeks, Opal began responding to loud noises, and after 24 weeks, she could hear whispers, indicating a near-normal level of hearing restoration.

Opal’s case is part of the Chord trial, which is recruiting more children from the UK, Spain, and the US to undergo similar treatment. The trial is being closely monitored, with participants followed up for five years to assess the long-term efficacy and safety of the therapy.

The success of this gene therapy is a beacon of hope for many suffering from genetic deafness, signaling the dawn of a new era in medical science where conditions once thought incurable are now within the realm of treatment. Opal’s story is not just a personal victory; it’s a milestone in genetic medicine, showcasing the incredible potential of gene therapy to change lives.

Labels:

Comments

Post a Comment